Form 8-K - Current report:
SEC Accession No. 0001193125-18-249889
Filing Date
2018-08-15
Accepted
2018-08-15 17:25:05
Documents
5
Period of Report
2018-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d610054d8k.htm 8-K 20640
2 EX-10.1 d610054dex101.htm EX-10.1 113533
3 EX-99.1 d610054dex991.htm EX-99.1 9091
4 GRAPHIC g610054g0815101708055.jpg GRAPHIC 25361
5 GRAPHIC g610054g0815101708289.jpg GRAPHIC 25992
  Complete submission text file 0001193125-18-249889.txt   215596
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 181021808
SIC: 2834 Pharmaceutical Preparations